|
GB9919413D0
(en)
*
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
AU7962200A
(en)
*
|
1999-10-29 |
2001-05-14 |
Wakunaga Pharmaceutical Co., Ltd |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
IL158168A0
(en)
*
|
2001-04-16 |
2004-03-28 |
Tanabe Seiyaku Co |
5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
|
|
ATE526319T1
(de)
|
2001-08-10 |
2011-10-15 |
Nippon Chemiphar Co |
Aktivator für den peroxisome proliferator- responsiven rezeptor delta
|
|
BRPI0213243B8
(pt)
|
2001-10-12 |
2021-05-25 |
Nippon Chemiphar Co |
composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
|
|
EP1771169A1
(en)
*
|
2004-07-14 |
2007-04-11 |
PTC Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
KR20070091607A
(ko)
*
|
2004-10-12 |
2007-09-11 |
디코드 제네틱스, 아이엔씨. |
폐쇄성 동맥 질환용의 설폰아미드 주변 치환된바이사이클릭 화합물
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
JP2009526863A
(ja)
*
|
2006-02-15 |
2009-07-23 |
アラーガン、インコーポレイテッド |
スフィンゴシン−１−リン酸（ｓ１ｐ）受容体アンタゴニスト生物学的活性を有するアリールまたはヘテロアリール基を持つインドール−３−カルボン酸アミド、エステル、チオアミドおよびチオールエステル化合物
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
ES2522291T3
(es)
|
2006-04-18 |
2014-11-14 |
Nippon Chemiphar Co., Ltd. |
Agente activador para el receptor activado por el proliferador de peroxisomas
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
RU2008149518A
(ru)
*
|
2006-05-16 |
2010-06-27 |
Декод Дженетикс, Ехф. (Is) |
Способ получения 7-(акрилоил) индолов
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
KR20090101307A
(ko)
|
2007-01-11 |
2009-09-24 |
알러간, 인코포레이티드 |
스핑고신-1-포스페이트(ｓ1ｐ) 수용체 길항제 생물학적 활성을 갖는 6-치환된 인돌-3-카르복실산 아미드 화합물
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
HUE039145T2
(hu)
|
2008-04-15 |
2018-12-28 |
Nippon Chemiphar Co |
Aktivátor peroxim proliferátor-aktivált receptorhoz
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
MX339950B
(es)
|
2010-03-12 |
2016-06-20 |
Omeros Corp |
Inhibidores de fosfodiesterasa 10 (pde10) y composiciones y metodos relacionados.
|
|
US9173887B2
(en)
|
2010-12-22 |
2015-11-03 |
Abbvie Inc. |
Hepatitis C inhibitors and uses thereof
|
|
AP2015008670A0
(en)
|
2013-02-21 |
2015-08-31 |
Adverio Pharma Gmbh |
Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate
|
|
NZ630803A
(en)
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
NZ716494A
(en)
|
2014-04-28 |
2017-07-28 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
MX380810B
(es)
|
2014-08-29 |
2025-03-12 |
Chdi Foundation Inc |
Sondas para la proyección de imagen de la proteína huntingtina.
|
|
WO2016172573A1
(en)
|
2015-04-24 |
2016-10-27 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
JP2018535969A
(ja)
|
2015-11-04 |
2018-12-06 |
オメロス コーポレーション |
Ｐｄｅ１０阻害剤の固体状態形態
|
|
BR112020009361A2
(pt)
|
2017-11-17 |
2020-10-13 |
Cellix Bio Private Limited |
composto de fórmula i, composição farmacêutica para tratar um distúrbio ocular ou complicações do mesmo, método de síntese de composto, método de tratamento de um distúrbio ocular ou complicações do mesmo em um indivíduo que precisa do mesmo e uso de um composto
|